<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU>

<div class=WordSection1>

<h1><span lang=EN-GB style='font-size:15.0pt;line-height:107%'>2002A09 Outline
the toxicity of local anaesthetics.</span></h1>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<h3><span lang=EN-GB style='font-size:13.0pt;line-height:107%'>List:</span></h3>

<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Determinants of LAST</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Amide thresholds</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>CNS toxicity</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>CVS toxicity</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Localised toxicity</span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Other</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<h3><span lang=EN-GB style='font-size:13.0pt;line-height:107%'>Determinants of
local anaesthetic toxicity (LAST):</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>↑Drug potency</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='font-family:"Cambria Math",serif'>∝</span><span
  lang=EN-GB> Lipid solubility (i.e. bupivacaine &gt;&gt; lignocaine)</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>↑Peak plasma concentration</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Main factors:</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>↑Dose</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>↑Rate of administration (bolus cf. infusion)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>↑Absorption rate (e.g. trachea, intercostal space)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>↓Metabolism rate (e.g. bupivacaine cf. lignocaine; liver disease)</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>↑CNS susceptibility</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>Pregnancy -&gt; ↑sensitivity</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>Altered seizure threshold: epilepsy</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>Drug interactions: tramadol, cocaine, class 1 antiarrhythmics</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>↑PaCO<sub>2</sub> (↑CBF), ↓PaO<sub>2</sub>, ↓pH</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>↑CVS susceptibility</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>Cardiovascular disease e.g. ischaemia</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>Drug interactions: class 1 antiarrhythmics</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>↑Heart rate -&gt; ↑channel cycling rate</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>↓PaO<sub>2</sub>, ↓pH, ↑K<sup>+</sup></span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>↓CC:CNS ratio</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>(safety margin)</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>Dynamics: ↑Cardiac:CNS isoform affinity ratio for VDNaC</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.55pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-GB>e.g.
  D-bupiv &gt; L-bupiv</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.25pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-GB>Kinetics (e.g. ↓lipid solubility): less important</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<h3><span lang=EN-GB style='font-size:13.0pt;line-height:107%'>Amide thresholds:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=174 valign=top style='width:130.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
  <td width=162 valign=top style='width:121.5pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span lang=EN-GB>Threshold</span></b></p>
  </td>
  <td width=316 valign=top style='width:236.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span lang=EN-GB>CC:CNS ratio</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=174 valign=top style='width:130.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Lignocaine</span></p>
  </td>
  <td width=162 valign=top style='width:121.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>5mcg/mL</span></p>
  </td>
  <td width=316 valign=top style='width:236.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>7:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=174 valign=top style='width:130.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Ropivacaine</span></p>
  </td>
  <td width=162 valign=top style='width:121.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>4mcg/mL</span></p>
  </td>
  <td width=316 valign=top style='width:236.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>5:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=174 valign=top style='width:130.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Bupivacaine</span></p>
  </td>
  <td width=162 valign=top style='width:121.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>1.5mcg/mL</span></p>
  </td>
  <td width=316 valign=top style='width:236.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>3:1</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<h3><span lang=EN-GB style='font-size:13.0pt;line-height:107%'>LAST: central
nervous effects</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Mechanism</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-GB>Inhibition of neuronal VDNaC</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Effects</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Initial
  excitatory effects</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.55pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-GB>Inhibition
  of inhibitory interneurons</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.55pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-GB>Peri-oral
  tingling, tinnitus, vertigo, slurred speech, inattention, twitching, seizures</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Then
  inhibitory effects</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.55pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-GB>Inhibition
  of excitatory interneurons and others</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.55pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-GB style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-GB>Coma,
  apnoea</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<h3><span lang=EN-GB style='font-size:13.0pt;line-height:107%'>LAST:
cardiovascular effects</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Mechanism</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Inhibition
  of cardiac VDNaC (very high affinity)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Inhibition
  of VDKC and VDCC (lower affinity)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>?↓cAMP</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Effects</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>First
  phase: ↑HR, ↑mAP</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Second
  phase: myocardial depression, ↓mAP</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Terminal
  phase: peripheral vasodilatation, ↓↓mAP, re-entrant arrhythmia, arrest</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>ECG</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>“As
  if being pulled apart” ↑QT<sub>C</sub>, ↑QRS duration</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Arrhythmias:
  sinus bradycardia, AV block, ventricular tachyarrhythmia, asystole</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<h3><span lang=EN-GB style='font-size:13.0pt;line-height:107%'>Localised
toxicity:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Transient neurological symptoms</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Associated
  with intrathecal lignocaine</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Moderate
  to severe pain in buttocks and thighs</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>No
  objective neurological deficit</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Onset:
  within 36 hours of complete recovery</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Offset:
  1-7 days</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Neurotoxicity</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Intra-neural
  injection</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Intrathecal
  injection -&gt; cauda equina syndrome to varying degree</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Cause:
  ? ↑ICF [Ca<sup>2+</sup>]</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Anterior spinal artery syndrome</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Lower
  limb paralysis</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Cause:
  ? thrombosis ?spasm ? hypotension ? vasoconstrictor</span></p>
  </td>
 </tr>
 <tr>
  <td width=102 valign=top style='width:76.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Total spinal anaesthesia</span></p>
  </td>
  <td width=550 valign=top style='width:412.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>If
  ↑↑ </span><span lang=EN-GB>intrathecal dose</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Unconsciousness,
  apnoea, ↓↓mAP</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<h3><span lang=EN-GB style='font-size:13.0pt;line-height:107%'>Other:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=110 valign=top style='width:82.7pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Hypersensitivity</span></p>
  </td>
  <td width=541 valign=top style='width:405.95pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>PABA
  metabolite of ester local anaesthetics</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Sodium
  metabisulfite</span></p>
  </td>
 </tr>
 <tr>
  <td width=110 valign=top style='width:82.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Methaemo-globinaemia</span></p>
  </td>
  <td width=541 valign=top style='width:405.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Hb
  with Fe<sup>3+</sup> is unable to bind O<sub>2</sub> or CO<sub>2</sub></span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Risk
  factors: dose &gt;600mg, neonate (↓reductase activity)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>Rx:
  methylene blue 1-2mg/kg IV over 5 mins</span></p>
  </td>
 </tr>
 <tr>
  <td width=110 valign=top style='width:82.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Cocaine toxicity</span></p>
  </td>
  <td width=541 valign=top style='width:405.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>CVS:
  noradrenaline reuptake inhibition -&gt; ↑ICF Ca<sup>2+</sup> -&gt; arrhythmias,
  coronary artery vasospasm -&gt; ischaemia</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB>CNS:
  dopamine and noradrenaline reuptake inhibition -&gt; euphoria, delirium,
  seizure</span></p>
  </td>
 </tr>
 <tr>
  <td width=110 valign=top style='width:82.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Hepatotoxicity</span></p>
  </td>
  <td width=541 valign=top style='width:405.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-GB>Associated with continuous or repeat use of
  bupivacaine</span></p>
  </td>
 </tr>
 <tr>
  <td width=110 valign=top style='width:82.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Respiratory depression</span></p>
  </td>
  <td width=541 valign=top style='width:405.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-GB>Lignocaine depresses ventilatory response to
  ↓PaO<sub>2</sub></span></p>
  </td>
 </tr>
 <tr>
  <td width=110 valign=top style='width:82.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-GB>Weakness</span></p>
  </td>
  <td width=541 valign=top style='width:405.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-GB>Potentiates non-depolarising neuromuscular
  blockade<br>
  (inhibit VDNaC on sarcolemma pre-synaptic membrane)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-GB>&nbsp;</span></p>

</div>

<p class="MsoNormal">Feedback welcome at <a href="mailto:ketaminenightmares@gmail.com">ketaminenightmares@gmail.com</a></p>
</body>

</html>
